Similar Stocks · Benchmarked Analysis · Peer Group

Peer Group Analysis

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Biotechnology Average - - - - - - 13,839.63 832.66 204.83 -184.21 35.91 0.00 18.4026 -0.38 -1.0577 -24.1364 -0.09 -0.11 7.4198 - -
Maximum - - - - - - 462,775.00 65,349.00 25,407.00 99,050.00 5,305.00 0.01 1,336.3467 6.70 3.0051 85.3485 0.15 8.35 61.5621 - -
Minimum - - - - - - 0.00 0.00 -1,175.00 -56,335.00 -1,185.00 0.00 -164.8536 -8.99 -101.7758 -1,444.7800 -1.56 -12.64 0.0007 - -
Reata Pharmaceuticals, Inc. RETA 172.36 0.04 0.02% 1,909 vs. 954 6,566.00 22.00 192.00 -70.00 -1,490.00 5.1200 5.4820 0.0000 0.9628 8.4849 2.2110 0.3840 2.8209 38.00
Madrigal Pharmaceuticals, Inc. MDGL 314.03 -1.12 -0.36% 101 vs. 354 6,849.00 0.00 -147.00 -149.00 -1,483.00 -7.3800 -8.6674 0.0000 0.0000 0.0000 -0.1734 -0.1363 9.2623 21.00
Revolution Medicines, Inc. RVMD 58.05 -0.09 -0.15% 259 vs. 1,146 9,764.00 0.00 -116.00 -163.00 -1,253.00 -0.7000 -11.2467 0.0000 0.0000 0.0000 -0.0672 -0.0608 18.1763 168.00
Akero Therapeutics, Inc. AKRO 30.75 -0.22 -0.71% 111 vs. 521 2,134.00 0.00 -53.00 -35.00 -627.00 -0.9000 -6.6902 0.0000 0.0000 0.0000 -0.0630 -0.0585 29.8643 69.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for AKRO and its peers to uncover potential buy and sell opportunities.